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Fibulin-2 is an extracellular matrix protein belonging to the five-member fibulin family, of which two
members have been shown to play essential roles in elastic fiber formation during development. Fibulin-2
interacts with two major constituents of elastic fibers, tropoelastin and fibrillin-1, in vitro and localizes to
elastic fibers in many tissues in vivo. The protein is prominently expressed during morphogenesis of the heart
and aortic arch vessels and at early stages of cartilage development. To examine its role in vivo, we generated
mice that do not express the fibulin-2 gene (Fbln2) through homologous recombination of embryonic stem cells.
Unexpectedly, the fibulin-2-null mice were viable and fertile and did not display gross and anatomical
abnormalities. Histological and ultrastructural analyses revealed that elastic fibers assembled normally in
the absence of fibulin-2. No compensatory up-regulation of mRNAs for other fibulin members was detected in
the aorta and skin tissue. However, in the fibulin-2 null aortae, fibulin-1 immunostaining was increased in the
inner elastic lamina, where fibulin-2 preferentially localizes. The results demonstrate that fibulin-2 is not
required for mouse development and elastic fiber formation and suggest possible functional redundancy
between fibulin-1 and fibulin-2.
Fibulins constitute a small family of five extracellular matrix
proteins that share a distinctive carboxyl-terminal globular do-
main and a tandem array of calcium-binding epidermal growth
factor-like modules (1, 25). Fibulin-1 and fibulin-2 contain an
additional domain of three anaphylatoxin modules preceding
the calcium-binding epidermal growth factor-like repeats
and therefore are larger than fibulin-3, -4, and -5, which have
identical modular structures. Fibulin-2 possesses a large amino-
terminal globular domain of approximately 400 amino acids
that is not present in the other fibulins and hence is the largest
member of the family (17). The protein is approximately 180
kDa in size and forms covalently linked dimers (22). The other
four fibulins range between 50 and 100 kDa in size and are
present mainly as monomers (8), though dimers of fibulin-5
have recently been described (31).
The fibulins not only share structural similarities but also
have overlapping expression patterns (4). A notable common
feature is that all fibulins are abundantly distributed in elastic
tissues, and all except fibulin-3 have been localized to elastic
fibers by immunoelectron microscopy (8, 18, 19, 27). However,
the fine localization of the fibulins within the elastic fibers is
not identical. While fibulin-2 and -4 are present at the interface
between the central elastin core and its surrounding fibrillin
microfibrils (8, 18), fibulin-1 is located within the elastin core
and fibulin-5 is associated with fibrillin microfibrils (8, 19).
Consistent with these observations, in vitro protein binding
studies have shown that all fibulins are capable of binding to
tropoelastin, albeit with different affinities (8, 20, 27), and that
fibulin-2, -4, and -5 interact with the N-terminal region of
fibrillin-1 (5, 6, 18).
The biological roles of most fibulins have been elucidated
through studies of gene-targeted mouse models. Fibulin-1 null
mice die perinatally, as a result of massive bleeding associated
with abnormal endothelial lining of small blood vessels and
severe defects in the basement membranes of many organs,
including the kidneys and lungs (10). There is no apparent
abnormality in elastic fiber formation. Mice deficient in fibu-
lin-3 show early aging and develop multiple large hernias in a
genetic background-dependent manner (12). A reduction in
elastic fibers specifically in fascia connective tissues may ex-
plain the herniation phenotype. Mice lacking either fibulin-4 or
fibulin-5 have highly disrupted and disorganized elastic fibers,
leading to developmental defects in skin, arterial blood vessels,
and lungs (13, 14, 27). Although the elastic fiber abnormalities
are similar in these two mouse mutants, the fibulin-4 null mice
are perinatally lethal, whereas the fibulin-5-deficient mice can
survive until adulthood. The animal models demonstrate that
fibulin-4 and fibulin-5 play essential yet nonredundant roles in
elastic fiber formation during development.
The in vivo function of fibulin-2 remains poorly understood.
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Here we report the generation and characterization of mice
deficient in fibulin-2. We show that the fibulin-2 null mice
develop normally and are phenotypically indistinguishable from
their wild-type littermates. Our study indicates that fibulin-2 is
dispensable for mouse development and elastic fiber formation,
possibly due to functional redundancy with fibulin-1.
MATERIALS AND METHODS
Construction of the targeting vector. A cosmid clone, T3b, containing the 5
portion of the mouse fibulin-2 gene was isolated from a 129/Sv genomic library
by screening with a mouse fibulin-2 cDNA clone as described previously (7). A
gene targeting vector was prepared using a 9.0-kb BamHI fragment isolated from
the cosmid, which contains the first coding exon (exon 2 of 1,288 bp) and its
flaking introns. A neomycin resistance gene driven by the phosphoglycerate
kinase promoter (PGK-Neo) was inserted by blunt-end ligation into the SpeI site
in exon 2 (see Fig. 1A). The PGK-Neo gene was in the same transcription
orientation as the fibulin-2 gene.
Generation of fibulin-2-deficient mice. The targeting vector, containing 5.0-kb
and 2.5-kb genomic sequences flanking the PGK-Neo cassette, was linearized
with NotI and electroporated into 5  107 mouse 129/Sv embryonic stem (ES)
cells (W9.5) under standard conditions (9). ES clones were selected with 250
g/ml G418 and analyzed by Southern blotting. Correctly targeted ES clones
were injected into blastocysts isolated from C57BL/6 mice and implanted into
pseudopregnant B6CBA F1 females to obtain chimeric mice. The chimeric
founders were mated with C57BL/6 mice to generate heterozygous Fbln2/
mice, which were intercrossed to produce homozygous Fbln2/ mice. Initial
phenotype analyses were performed with littermates on a mixed 129/Sv and
C57BL/6 background. The Fbln2 null allele was introduced into two different
genetic backgrounds, 129S1/SvImJ and C57BL/6J, by backcrossing for 10 gener-
ations. All animal procedures described in this study were performed in accor-
dance with the National Institutes of Health Guidelines for the Care and Use of
Laboratory Animals, and all experimental protocols were approved by the Insti-
tutional Animal Care and Use Committee of Thomas Jefferson University.
Genotyping of ES cells and mice. Genomic DNA was isolated from ES cells
and mouse tails, digested with EcoRI, separated on 0.7% agarose gels, trans-
ferred to Hybond nylon membranes (GE Healthcare, Piscataway, NJ), and hy-
bridized with a 3.5-kb EcoRI-XhoI external probe (see Fig. 1A) labeled with
[32P]dCTP using a random prime labeling system (Rediprime II; GE Health-
care). Genotyping of mice was also carried out by PCR amplification of the tail
DNA. A 480-bp PCR product from the wild-type allele was detected using
primers 5-CTACGGCCATTGTGAACGAG-3 and 5-GTGATCGCTGGGC
TTTACTG-3, located in exon 2. The targeted allele yielded a 331-bp product
with primers 5-GCCAAAGCCAGGAGAGTGAC-3 and 5-ACCGGTGGAT
GTGGAATGTG-3, located in exon 2 and the PGK-Neo gene, respectively.
Cell cultures. Embryonic fibroblasts were prepared from carcasses of embryos
at 16 days postcoitum using littermates from intercrossing heterozygous animals.
Cells were cultured in Dulbecco’s modified Eagle’s medium with 10% fetal
bovine serum (Invitrogen, Carlsbad, CA). For immunofluorescence analysis,
cells were grown in eight-chamber slides (Nalge Nunc, Rochester, NY) for 7 days
postconfluency.
Northern blot analysis. Total RNA from mouse embryonic fibroblasts and
adult mouse tissues were isolated using the Totally RNA kit (Ambion, Austin,
TX). Ten micrograms of the RNA samples were electrophoresed on a 1%
agarose gel containing 6% formaldehyde, transferred to nylon membranes
(Stratagene, La Jolla, CA), and hybridized to cDNA probes radiolabeled with
[32P]dCTP by the Rediprime II labeling system (GE Healthcare). The cDNA
fragments used for probing the Northern blots were amplified from mouse
embryonic fibroblast RNA by reverse transcription-PCR and then cloned into
the pCRII plasmid (Invitrogen). Hybridization signals were detected by a
PhosphorImager (Molecular Dynamics, Sunnyvale, CA).
Western blot analysis. Confluent fibroblasts were grown in Dulbecco’s modi-
fied Eagle’s medium (Invitrogen) in the absence of serum for 24 h. One hundred
microliters serum-free medium was precipitated with 900 l of 100% ethyl
alcohol, the protein pellet resuspended in Laemmli sample buffer containing 62.5
mM Tris-HCl (pH 6.8), 2% sodium dodecyl sulfate, 25% glycerol, and 0.01%
bromophenol blue, electrophoresed through 4 to 12% sodium dodecyl sulfate-
polyacrylamide gradient gels, and transferred to polyvinylidene difluoride mem-
branes (GE Healthcare). The membranes were incubated with polyclonal anti-
bodies against fibulin-2 (17) and the 1(VI) collagen chain (24). Positive signals
were detected by the ECL Plus chemiluminescent reagent (GE Healthcare).
Histology and immunohistochemistry. For histological analyses, mouse tissues
were fixed with 10% buffered formalin for 1 to 3 days, dehydrated through a
graded ethanol series, and embedded in paraffin. Sections 5 m thick were
stained with hematoxylin-eosin, Masson’s trichrome collagen stain, or Verhoeff’s
van Gieson elastin stain. Immunohistochemistry was performed using 6- to
8-m-thick cryosections of mouse tissues or fibroblasts grown on chamber slides
by the method described elsewhere (26). Primary antibodies included those
specific for each of the five fibulins (1:1,000 dilution) (8, 17), fibrillin-1 (a
generous gift of Lynn Sakai), elastin (PR387; Elastin Products Company, Owens-
ville, MO), and fibronectin (Sigma, St. Louis, MO). Cy3-conjugated anti-rabbit
immunoglobulin G (1: 800 dilution; Jackson ImmunoResearch Laboratory, West
Grove, PA) was used as the secondary antibody. Nuclei were counterstained with
4, 6-diamidino-2-phenylindole hydrochloride. Images were captured using a
Zeiss Axioskop epifluorescence microscope with a Toshiba 3CCD camera and
ImagePro software (Media Cybernetics, Silver Spring, MD).
Elastin content measurement. Descending aortae from adult mice were dis-
sected, and the desmosine/isodesmosine contents were determined using a Beck-
man 6300 amino acid analyzer as previously described (3).
Electron microscopy. Descending aortae and back skin were dissected from
adult wild-type and fibulin-2 null mice, and samples for transmission electron
microscopy were prepared as described previously (2). Briefly, tissues were fixed
in 4% paraformaldehyde, 2.5% glutaraldehyde, and 0.1 M sodium cacodylate
(pH 7.4) with 8.0 mM CaCl2 and then post-fixed with 1% osmium tetroxide
(containing 2% tannic acid for aorta samples only). After dehydration in an
ethanol series, followed by propylene oxide, the samples were infiltrated and
embedded in a mixture of EMbed 812, nadic methyl anhydride, dodecenyl
succinic anhydride, and DMP-30 (Electron Microscopy Sciences, Hatfield, PA).
Thin sections were cut using a Reichert UCT ultramicrotome and post-stained
with aqueous uranyl acetate followed by phosphotungstic acid or lead citrate.
FIG. 1. Generation of the fibulin-2 null mice. (A) Schematic dia-
gram of the mouse fibulin-2 gene, the targeting vector, and the mutant
allele after homologous recombination. The targeting vector contains
a PGK-Neo gene (NEO) flanked by LoxP sequences inserted into the
SpeI site of exon 2 (black box) by blunt-end ligation, resulting in the
deletion of the SpeI site and addition of an EcoRI site located in
the PGK-Neo fragment. Restriction sites shown are BamHI (B),
EcoRI (E), XhoI (X), HindIII (H), and SpeI (Spe). The translation
start site (ATG) and the probe used for Southern blotting are indi-
cated. (B) Southern blot analysis of mouse tail DNA digested with
EcoRI. (C) Northern blot analysis of total RNA isolated from embry-
onic fibroblasts of the Fbln2/, Fbln2/, and Fbln2/ mice using
full-length mouse fibulin-2 cDNA as a probe (top panel). Ethidium
bromide staining of 28S RNA is shown in the bottom panel. (D) West-
ern blot analysis of culture medium from mouse fibroblasts of the three
genotypes, using antibodies specific for fibulin-2 and the 1(VI) col-
lagen (Col6a1).
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Sections were examined at 80 kV using a Tecnai12 transmission electron micro-
scope equipped with a Gatan Ultrascan US1000 2 K digital camera.
RESULTS
Generation of fibulin-2-deficient mice. The gene targeting
vector was designed to disrupt the fibulin-2 gene by inserting
the PGK-Neo cassette after codon 282. Approximately 400
G418-resistant ES clones were screened by Southern blotting
with the 3 external probe, which detected a 17-kb EcoRI band
from the wild-type allele and a 10-kb EcoRI band from the
targeted allele (Fig. 1A and B). The screening revealed that
approximately 10% of the clones were correctly targeted. Four
of the targeted ES clones were microinjected into the C57BL/6
blastocytes, and Fbln2/ mice were obtained from chimeric
founders from each ES cell clone. Intercrossing of the het-
erozygous (Fbln2/) F1 mice from each ES cell clone yielded
offspring of the three genotypes (Fbln2/, Fbln2/, and
Fbln2/) at the expected Mendelian frequencies. Embryonic
fibroblasts originating from the Fbln2/, Fbln2/, and
Fbln2/ littermates were analyzed by Northern and Western
blotting. The results confirmed the absence of fibulin-2 mRNA
and protein in the Fbln2 null animals and indicated that
the heterozygous animals expressed approximately half the
amounts of mRNA and protein expressed in the wild-type mice
(Fig. 1C and D).
Fibulin-2-deficient mice are fertile and have no gross ab-
normalities. The Fbln2/ mice on either a 129S1/SvImJ or a
C57BL/6J background did not display any apparent, abnormal
phenotype. No statistically significant differences in body
weights were observed between the Fbln2/, Fbln2/, and
Fbln2/ mice, indicating normal growth. Since fibulin-2 ex-
pression is specifically associated with cardiovascular morpho-
genesis (26, 28), anatomical analyses were performed on mice
at days 11 and 13 of embryonic development and adult stages
(6 to 8 weeks). There were no noticeable differences in the
morphology of cardiac valves and major blood vessels between
the Fbln2/ and Fbln2/ animals. Inbreeding of Fbln2/
mice resulted in litters with numbers of pups per litter and
pups of normal weight and appearance equal to those of
Fbln2/ litters. The number of litters produced by the male
and female Fbln2/ animals was indistinguishable from that
of their wild-type counterparts. The Fbln2/ mice had a nor-
mal life span, surviving beyond 2 years of age.
Loss of fibulin-2 does not affect elastogenesis. Histological
and ultrastructural analyses were carried out with two elastic
fiber-enriched organs, aorta and skin, from the adult mice. As
shown in Fig. 2, the elastic laminae of the ascending aorta
formed normally in the Fbln2/ mice. Analysis of C57BL/6
Fbln2/ congenic mice revealed that the number of aortic
laminar units in the Fbln2/ mice was not significantly differ-
ent from that in the Fbln2/ mice. The amounts of cross-
linked elastin (pmole desmosine/mg protein), determined by
the desmosine contents of the aortae, were comparable be-
tween the Fbln2/ and Fbln2/ mice (for Fbln2/ mice,
47.6  14.4 [n  5]; for Fbln2/ mice, 41.7  10.9 [n  6]).
Ultrastructural examination of the Fbln2/ aortae by trans-
mission electron microscopy confirmed that the elastic laminae
were not disrupted (Fig. 3). The connective tissue layer, con-
sisting mainly of collagen fibrils, between smooth muscle cells
and the elastic laminae appeared to be decreased in the
Fbln2/ mice compared to that in the Fbln2/ animals. Skin
from the Fbln2/ mice appeared normal by histological stain-
ing with hematoxylin/eosin, Masson’s trichrome collagen stain,
and Verhoeff’s Van Gieson elastin stain (Fig. 2). Ultrastruc-
tural analyses of the skin did not reveal apparent differences in
either collagen fibrils or elastic fibers between Fbln2/ and
Fbln2/ animals (Fig. 4).
Altered distribution of fibulin-1 in the fibulin-2-deficient
aorta. Cryosections of the skin and descending aortae were
immunostained with antibodies specific for elastin, fibrillin-1,
and each of the five fibulins. There was no significant difference
in the expression of these proteins in the skin of the Fbln2/
mice and Fbln2/ mice. However, immunostaining of aorta
sections showed that fibulin-1 expression was significantly in-
creased in the internal elastic lamina of the Fbln2/ null mice
compared to levels for wild-type mice (Fig. 5). In the wild-type
aorta, fibulin-2 expression was most prominent in the inner
elastic lamina along the endothelial basement membrane and
fibulin-1 was evenly distributed in all elastic laminae. The dis-
tribution of fibulin-3, -4, and -5 protein in the Fbln2/ aortae
FIG. 2. Histological analysis of ascending aortae and skin from
Fbln2/ and Fbln2/ mice. (A to D) Paraffin-embedded aortic sec-
tions were stained with Verhoeff’s solution, in which elastin appears
dark brown or black. Images were taken at two different magnifica-
tions. Arrows indicate elastin laminae. Magnification bar 100 m. (E
to J) Skin sections were subjected to hematoxylin-eosin (E and H),
Masson’s trichrome collagen (F and I), and Verhoeff’s van Gieson
elastin (G and J) stains. Bars  100 m.
VOL. 28, 2008 FIBULIN-2 KNOCKOUT MICE 1063
 o
n
 January 11, 2014 by W








was unchanged (data not shown). To determine whether fibu-
lin-2-deficient cells deposited more fibulin-1 protein, Fbln2/
and Fbln2/ embryonic fibroblasts were cultured for 7 days
postconfluency and immunostained with antibodies against
fibulin-1 and fibulin-2. The fibulin-1 fibrils deposited by fibro-
blasts from these two genotypes were comparable (Fig. 6).
No compensatory up-regulation of mRNA expression for
other fibulin members. To determine whether loss of fibulin-2
results in a change in gene expression of the other fibulins,
total RNA extracted from the aorta and skin of the newborn
mice was evaluated by Northern blot analyses. The amounts of
fibulin-1, -3, -4, and -5 mRNA were not significantly different
in the Fbln2/ and Fbln2/ animals (Fig. 7).
Matrix assembly by fibulin-2 null fibroblasts is not compro-
mised. Previous studies have shown that fibulin-2 can be in-
corporated into both elastic fibers and the fibronectin matrix
(18, 23). To determine whether the absence of fibulin-2 alters
the assembly of fibronectin or elastic fibers, embryonic fibro-
blasts from the Fbln2/ and Fbln2/ animals grown for 7
days after confluence were immunostained with antibodies
against elastin, fibrillin-1, and fibronectin. There were no sig-
nificant differences in the intensity or pattern of immunostain-
ing of the extracellular matrix produced by fibroblasts from the
two genotypes (Fig. 8).
DISCUSSION
We have generated a mouse deficient in fibulin-2 in order to
understand its biological role in vivo. Our previous studies
demonstrate that fibulin-2 expression is prominent and highly
specific at embryonic sites of epithelial-mesenchymal transfor-
mation (26, 28, 29). Expansion of the fibulin-2 extracellular
network is associated with mesenchymal cells that have mi-
grated into the endocardial cushion tissue, aortic arch vessels,
FIG. 3. Transmission electron micrographs of descending aortae
from Fbln2/ and Fbln2/ mice. (A and B) Low-magnification mi-
crographs with the luminal side of the aorta on top. Note that the
elastic laminae (EL) in the fibulin-2-deficient mice form normally, but
the space (*) between the smooth muscle cell (SMC) and elastic
lamina appears to be narrower than that for the wild-type mice. (C to
F) High-magnification micrographs showing the internal elastic lamina
(IEL, panels C and D) and the elastic lamina (EL) in the medial layer
(E and F) of the aorta are comparable between the fibulin-2 null and
wild-type mice.
FIG. 4. Transmission electron micrographs of the dermis from
Fbln2/ and Fbln2/ mice. (A and B) Low-magnification micrographs
show that the elastic fibers (arrowheads) and collagen fibrils (arrows) are
comparable in the fibulin-2-deficient and wild-type mice. (C to F) High-
magnification micrographs showing elastic fibers and collagen fibrils in
cross sections (C and D) and longitudinal sections (E and F).
FIG. 5. Immunofluorescence staining of ascending aortae from
Fbln2/ and Fbln2/ mice. Frozen sections were stained with poly-
clonal antibodies against fibulin-2 (A and C) or fibulin-1 (B and D).
Arrows indicate the internal elastic laminae. Bars  100 m.
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and coronary vessels during cardiovascular development (26).
High levels of fibulin-2 protein expression are also found in
developing hair follicles and precartilage condensation sites
(29). These observations suggest that fibulin-2 may promote
proliferation, differentiation, and migration of mesenchymal
cells during organogenesis. It is therefore surprising that a total
absence of fibulin-2 does not have discernible effects on em-
bryonic and postnatal development of the mice. In particular,
the Fbln2/ mice do not show developmental delay or abnor-
malities in the cardiovascular system.
Several lines of evidence suggest that fibulin-2 may have a
role in male and female reproduction. A correlation has been
found between postnatal development of testis and fibulin-2
expression in the basement membrane of seminiferous tubule
in rats (11). Human ovary tissue has been shown to express
high levels of fibulin-2 mRNA (30). Moreover, a recent study
suggests that fibulin-2 and fibulin-1 may be involved in seques-
tering sex hormone-binding globulin within the uterine stroma
and epididymis, thereby controlling sex-steroid access to target
cells (15). However, the results presented here show that both
male and female Fbln2/ mice are fertile, indicating that
fibulin-2 is not required for normal reproductive function.
Fibulin-2, like fibulin-4 and -5, binds to tropoelastin and
fibrillin-1 in vitro and localizes to elastic fibers in vivo (18, 20).
However, unlike the case with fibulin-4- or fibulin-5-deficient
mice, histological and ultrastructural analyses of the fibulin-2-
deficient mice demonstrate that a lack of fibulin-2 does not
affect elastic fiber formation in vivo. Consistent with this find-
ing, embryonic fibroblasts deficient in fibulin-2 are capable of
depositing the fibrillar matrix of elastin, fibrillin-1, and fi-
bronectin. Since members of the fibulin family display overlap-
ping developmental expression, tissue distribution, and molec-
ular interactions (4, 25), a loss of fibulin-2 likely can be
compensated by other family members. In particular, the tissue
distribution of fibulin-2 is substantially more restricted than
that of the other four fibulins. For instance, in the lung, fibu-
lin-2 is present only in the blood vessels, whereas the other four
fibulins are also found, to various extents, in the airways and
parenchyma (8). Moreover, the content of fibulin-2 in protein
extracts from most organs, as determined by radioimmunoin-
hibition assays, is considerably less than that of fibulin-1 and -5
and is similar to that of fibulin-3 and -4 (8).
Northern blot analyses show that the mRNA levels of the
other four fibulins are not changed for the fibulin-2 null mice
from that for controls. On the other hand, immunostaining
studies of the fibulin-2 null mice show increased fibulin-1 pro-
tein expression in the inner elastic lamina of the aorta, where
fibulin-2 is normally localized. This indicates that a loss of
fibulin-2 leads to an alteration in the localization of the fibu-
lin-1 protein within the aorta rather than a change in its gene
expression. It is possible that in the inner elastic lamina of the
fibulin-2 null mice, the fibulin-1 protein is bound to molecules
that normally interact with fibulin-2 and is thereby less prone
to removal or degradation. Fibulin-2, like fibulin-1 but unlike
fibulin-3, -4, and -5, binds fibronectin and several basement
membrane and cartilage proteins, including laminin 2 and 	2
chains, nidogen, collagen XVIII, vesican, and aggrecan (8, 16,
21). It is thus conceivable that a loss of fibulin-2 could readily
be compensated for by fibulin-1 but not by fibulin-3, -4, and -5.
On the other hand, compensation by other fibulin family mem-
bers, though not detected in this study, cannot be excluded.
Our previous finding that the fibulin-1 null mice display a
perinatally lethal phenotype (10) suggests that fibulin-2 is un-
able to functionally compensate for the loss of fibulin-1. The
lack of compensation for fibulin-1 could be explained by the
following points. Fibulin-1 is an integral component of all base-
ment membranes, and consequently its expression initiates
very early during embryonic development (26). The lethal phe-
notype of the fibulin-1 null mice results largely from bleeding
due to a defective endothelial basement membrane of small
but not large blood vessels (10). On the other hand, fibulin-2
has a more restricted expression pattern and is not present in
the small blood vessels (26). Its expression during embryogen-
FIG. 6. Immunofluorescence staining of embryonic fibroblasts
from Fbln2/ and Fbln2/ mice with antibodies against mouse fibu-
lin-2 (A and C) and fibulin-1 (B and D). Bars  100 m.
FIG. 7. Northern blot analysis of total RNA isolated from skin and
aorta of Fbln2/ and Fbln2/ mice. Ten micrograms of RNA in each
lane was hybridized with [32P]dCTP-labeled cDNA probes for fibulins
and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Each lane
contains total RNA extracted from a separate animal. There is no
significant difference between the two genotypes.
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esis initiates substantially later than that of fibulin-1 (26).
Moreover, fibulin-2 is significantly less abundant than fibulin-1,
present at a level of only 10 to 30% of that of fibulin-1 in
various organs (8). Though fibulin-1 and fibulin-2 share similar
modular structures and binding interactions, the temporal,
spatial, and quantitative expression differences prevent fibu-
lin-2 from serving the full functions of fibulin-1.
In conclusion, our studies demonstrate that fibulin-2 is not
essential for development, fertility, and elastogenesis. This
could be attributed to functional compensation by other mem-
bers of the fibulin protein family. Testing this hypothesis will
depend on the characterization of mice deficient in two or
more fibulins.
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